Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics, Inc. (QNCX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $32.3M; returns 1 day +0.8%, 1 week +3.3%, 1 year -90.7%.

Quince Therapeutics, Inc. (QNCX) is a late-stage biopharmaceutical company focused on acquiring, developing, and commercializing therapeutics for rare diseases by leveraging a patient's own biology. Their core technology is the autologous intracellular drug encapsulation (AIDE) platform.

Groups QNCX belongs to

• Biotechnology
• Recent Reverse Splits
• Rare Diseases
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Healthcare
• Neuroscience
• Autologous Cell Therapy

QNCX financial model: income statement, cash flow and balance sheet